BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38570935)

  • 1. Deciphering cutaneous melanoma prognosis through LDL metabolism: Single-cell transcriptomics analysis via 101 machine learning algorithms.
    Xie J; Wu D; Zhang P; Zhao S; Qi M
    Exp Dermatol; 2024 Apr; 33(4):e15070. PubMed ID: 38570935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The fatty acid-related gene signature stratifies poor prognosis patients and characterizes TIME in cutaneous melanoma.
    Hua S; Wang W; Yao Z; Gu J; Zhang H; Zhu J; Xie Z; Jiang H
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):40. PubMed ID: 38279987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma.
    Ding Y; Zhao Z; Cai H; Zhou Y; Chen H; Bai Y; Liu Z; Liu S; Zhou W
    Front Immunol; 2023; 14():1304466. PubMed ID: 38077400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma.
    Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of immune-related genes with prognostic significance in the microenvironment of cutaneous melanoma.
    Qu Y; Zhang S; Zhang Y; Feng X; Wang F
    Virchows Arch; 2021 May; 478(5):943-959. PubMed ID: 33179141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma.
    Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L
    Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma.
    Tian Q; Gao H; Zhao W; Zhou Y; Yang J
    Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes associated with cellular senescence favor melanoma prognosis by stimulating immune responses in tumor microenvironment.
    Liang X; Lin X; Lin Z; Lin W; Peng Z; Wei S
    Comput Biol Med; 2023 May; 158():106850. PubMed ID: 37031510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma.
    Wu M; Wang Z; Zhang J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of ferroptosis-related lncRNA signature and immune-related gene signature for predicting the prognosis of cutaneous melanoma patients.
    Xiong K; Wang Z; Hounye AH; Peng L; Zhang J; Qi M
    Apoptosis; 2023 Jun; 28(5-6):840-859. PubMed ID: 36964478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive analysis of ferroptosis-related genes and prognosis of cutaneous melanoma.
    Liu C; Liu Y; Yu Y; Zhao Y; Yu A
    BMC Med Genomics; 2022 Mar; 15(1):39. PubMed ID: 35232428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
    Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
    Front Immunol; 2022; 13():967277. PubMed ID: 36466837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of an endoplasmic reticulum stress-associated gene signature to predict the immune status and prognosis of cutaneous melanoma.
    Chen R; Niu L; Wu L; He Y; Liu G; Hong K
    Medicine (Baltimore); 2022 Sep; 101(36):e30280. PubMed ID: 36086718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a pyroptosis-associated long non-coding RNA signature for predicting the immune status and prognosis in skin cutaneous melanoma.
    Wu L; Liu G; He YW; Chen R; Wu ZY
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5597-5609. PubMed ID: 34604952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined signature of G protein-coupled receptors and tumor microenvironment provides a prognostic and therapeutic biomarker for skin cutaneous melanoma.
    Song B; Wang K; Peng Y; Zhu Y; Cui Z; Chen L; Yu Z; Song B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18135-18160. PubMed ID: 38006451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of lactylation gene CALML5 and its correlated lncRNAs in cutaneous melanoma by machine learning.
    Feng H; Chen W; Zhang C
    Medicine (Baltimore); 2023 Nov; 102(47):e35999. PubMed ID: 38013352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leveraging a disulfidptosis-related signature to predict the prognosis and immunotherapy effectiveness of cutaneous melanoma based on machine learning.
    Zhao Y; Wei Y; Fan L; Nie Y; Li J; Zeng R; Li J; Zhan X; Lei L; Kang Z; Li J; Zhang W; Yang Z
    Mol Med; 2023 Oct; 29(1):145. PubMed ID: 37884883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of Circadian Clock Signature for Tumor Microenvironment in Predicting Survival for Cutaneous Melanoma.
    Zeng N; Xia Q; Li Y; Ma L; Cheng Y; Chen Y; Lu Q; Lu Z; Wu D; Luo D
    Curr Pharm Des; 2022; 28(28):2349-2361. PubMed ID: 35927923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative analysis of bulk and single-cell RNA-seq reveals the molecular characterization of the immune microenvironment and oxidative stress signature in melanoma.
    Li Y; Jiang B; Chen B; Zou Y; Wang Y; Liu Q; Song B; Yu B
    Heliyon; 2024 Mar; 10(6):e28244. PubMed ID: 38560689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bulk and single-cell RNA-sequencing analyses along with abundant machine learning methods identify a novel monocyte signature in SKCM.
    Liu Y; Zhang H; Mao Y; Shi Y; Wang X; Shi S; Hu D; Liu S
    Front Immunol; 2023; 14():1094042. PubMed ID: 37304304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.